Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001641172-25-011519
Filing Date
2025-05-19
Accepted
2025-05-19 17:23:12
Documents
15
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A form10-qa.htm   iXBRL 10-Q/A 62138
2 EX-31.1 ex31-1.htm EX-31.1 6271
3 EX-31.2 ex31-2.htm EX-31.2 6341
4 EX-32.1 ex32-1.htm EX-32.1 10261
  Complete submission text file 0001641172-25-011519.txt   279395

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE immx-20250331.xsd EX-101.SCH 3014
6 XBRL LABEL FILE immx-20250331_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE immx-20250331_pre.xml EX-101.PRE 22358
17 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 7479
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-41159 | Film No.: 25965168
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)